Specific Dioscorea Phytoextracts Enhance Potency of TCL-Loaded DC-Based Cancer Vaccines
Figure 6
Adjuvant effect of DsII-TN5 on antimelanoma immunity in a mouse model. (a) Schema of preparation of DC-based cancer vaccines. (b) Tumor growth and (c) survival rates in tumor-bearing mice after tumor challenge. All data are expressed as mean ± SE. (d) Percentage of MDSCs (CD11b+Gr-1+) was analyzed using flow cytometry, calculated, and presented in the bar chart. (e) Data represent the mean ± SD of three replicates.
